Answers are grounded in this paper and cite their sources.
Minireview discusses O-GlcNAc's role in cancer cell behavior, indicating therapeutic modification potential.
O-Linked β-N-acetylglucosamine (O-GlcNAc) is a carbohydrate post-translational modification on hydroxyl groups of serine and/or threonine residues of cytosolic and nuclear proteins. Analogous to phosphorylation, O-GlcNAcylation plays crucial regulatory roles in cellular signaling. Recent work indicates that increased O-GlcNAcylation is a general feature of cancer and contributes to transformed phenotypes. In this minireview, we discuss how hyper-O-GlcNAcylation may be linked to various hallmarks of cancer, including cancer cell proliferation, survival, invasion, and metastasis; energy metabolism; and epigenetics. We also discuss potential therapeutic modulation of O-GlcNAc levels in cancer treatment.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: